Medication safety principles and practice in CKD

75Citations
Citations of this article
254Readers
Mendeley users who have this article in their library.

Abstract

Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source ofmedical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated via the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury andmetabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and reviewthe complications of a range ofmedications routinely administered in CKD, as these also call for cautious use.

Cite

CITATION STYLE

APA

Whittaker, C. F., Miklich, M. A., Patel, R. S., & Fink, J. C. (2018). Medication safety principles and practice in CKD. Clinical Journal of the American Society of Nephrology. American Society of Nephrology. https://doi.org/10.2215/CJN.00580118

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free